Total Payments
$3,346
2024 Payments
$254.75
Companies
17
Transactions
49
Medicare Patients
421
Medicare Billing
$66,013
Payment Breakdown by Category
Food & Beverage$3,346 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,346 | 49 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $790.22 | 16 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $729.48 | 8 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $276.77 | 4 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $245.81 | 2 | $0 (2019) |
| Lilly USA, LLC | $234.71 | 3 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $139.14 | 2 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $130.17 | 3 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $129.95 | 1 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $124.99 | 1 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $124.80 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $254.75 | 2 | Regeneron Healthcare Solutions, Inc. ($129.95) |
| 2022 | $249.97 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($124.99) |
| 2021 | $121.84 | 1 | GlaxoSmithKline, LLC. ($121.84) |
| 2020 | $205.97 | 2 | Janssen Pharmaceuticals, Inc ($112.50) |
| 2019 | $922.41 | 13 | Janssen Pharmaceuticals, Inc ($454.09) |
| 2018 | $764.00 | 14 | AstraZeneca Pharmaceuticals LP ($276.77) |
| 2017 | $826.92 | 15 | Novartis Pharmaceuticals Corporation ($241.75) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $129.95 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/25/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: Cardiology | ||||||
| 05/28/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardio-renal | ||||||
| 05/12/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/13/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2020 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $93.47 | General |
| Category: Respiratory and Allergy | ||||||
| 01/30/2020 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $112.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/12/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $104.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/17/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $102.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/30/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/16/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $121.36 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $122.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/05/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $4.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/28/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $7.24 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/06/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $2.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/21/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $104.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/16/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $98.37 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/07/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $123.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/23/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/14/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $113.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/20/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/19/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/07/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/17/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $123.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/10/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $121.62 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 35 | 67 | $7,695 | $3,310 |
| 2022 | 4 | 72 | 275 | $34,630 | $16,512 |
| 2021 | 6 | 129 | 389 | $46,080 | $23,567 |
| 2020 | 8 | 185 | 480 | $54,650 | $22,624 |
Total Patients
421
Total Services
1,211
Medicare Billing
$66,013
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 11 | 33 | $4,125 | $1,719 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 34 | $3,570 | $1,591 | 44.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 16 | 149 | $18,625 | $8,143 | 43.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 93 | $9,765 | $5,138 | 52.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 18 | $3,240 | $1,626 | 50.2% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 13 | 15 | $3,000 | $1,605 | 53.5% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 26 | 203 | $25,375 | $11,549 | 45.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 115 | $12,075 | $7,067 | 58.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 23 | $4,140 | $2,320 | 56.0% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 18 | 18 | $3,600 | $1,972 | 54.8% |
| 90674 | Vaccine for influenza derived from cell cultures for administration into muscle, 0.5 ml dosage, quadrivalent, , preservative and antibiotic free | Office | 2021 | 16 | 16 | $400.00 | $400.00 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 14 | 14 | $490.00 | $259.42 | 52.9% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 46 | 220 | $27,500 | $10,837 | 39.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 46 | 137 | $14,385 | $5,897 | 41.0% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2020 | 26 | 27 | $5,400 | $2,829 | 52.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 24 | $4,320 | $1,745 | 40.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 12 | 22 | $1,760 | $617.24 | 35.1% |
| 90674 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 14 | 15 | $375.00 | $374.50 | 99.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 14 | 14 | $490.00 | $256.62 | 52.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 11 | 21 | $420.00 | $68.11 | 16.2% |
About Dr. Anil Vithala, MD
Dr. Anil Vithala, MD is a Internal Medicine healthcare provider based in East Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1083601256.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anil Vithala, MD has received a total of $3,346 in payments from pharmaceutical and medical device companies, with $254.75 received in 2024. These payments were reported across 49 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,346).
As a Medicare-enrolled provider, Vithala has provided services to 421 Medicare beneficiaries, totaling 1,211 services with total Medicare billing of $66,013. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location East Hartford, CT
- Active Since 10/04/2005
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1083601256
Products in Payments
- ENTRESTO (Drug) $729.48
- XARELTO (Drug) $426.74
- INVOKANA (Drug) $363.48
- FARXIGA (Drug) $276.77
- JARDIANCE (Drug) $139.14
- DUPIXENT (Biological) $129.95
- Kerendia (Drug) $124.99
- UPTRAVI (Drug) $124.80
- Utibron (Drug) $124.45
- NUCALA (Biological) $121.84
- LONHALA MAGNAIR (Drug) $121.36
- NUEDEXTA (Drug) $113.33
- TRULICITY (Drug) $110.18
- TOUJEO (Drug) $106.35
- Yupelri (Drug) $93.47
- LINZESS (Drug) $24.73
- SOLIQUA (Drug) $23.82
- NAMZARIC (Drug) $22.07
- XIFAXAN (Drug) $16.87
- FLUZONE HIGH-DOSE (Drug) $14.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in East Hartford
Dr. Adarsh Jha, M.d, M.D
Internal Medicine — Payments: $23,292
Internal Medicine $23,292
Ronald Kimmel, Md, MD
Internal Medicine — Payments: $19,191
Internal Medicine $19,191
David Mintell, Md, MD
Internal Medicine — Payments: $7,967
Internal Medicine $7,967
Usman Ramzan, Md, MD
Internal Medicine — Payments: $2,485
Internal Medicine $2,485
Anum Ahmed, M.d, M.D
Internal Medicine — Payments: $506.29
Internal Medicine $506.29
Michael Collins, Md, MD
Internal Medicine — Payments: $365.79
Internal Medicine $365.79